|
Translational Physician-Scientist Training Program in Oncology
|
4T32CA160040-04
|
$252,582
|
$63,146
|
SHIN, DONG
|
EMORY UNIVERSITY
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$18,492
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Molecular Targeted Photoimmunotherapy for Bladder Cancer
|
ZIA BC 011458
|
$538,087
|
$538,087
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$179,362
|
$179,362
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Contribution of Y-specific Genes to Bladder Cancer
|
ZIA BC 011591
|
$11,957
|
$11,957
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Evaluation of Protein Kinase D1 in Bladder Cancer as a possible oncogene
|
ZIA BC 011592
|
$239,150
|
$239,150
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Investigation of Epigenetic Modifiers in Bladder Cancer
|
ZIA BC 011593
|
$59,787
|
$59,787
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Targeting Metabolic Pathways in Bladder Cancer
|
ZIA BC 011741
|
$107,617
|
$107,617
|
Agarwal, Piyush
|
CCR (NCI)
|
|
High Throughput Screening of Agents in Bladder Cancer Cell Lines
|
ZIC BC 011531
|
$59,787
|
$59,787
|
Agarwal, Piyush
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
$39,573
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bladder Cancer Program
|
ZIA BC 011351
|
$359,376
|
$359,376
|
Apolo, Andrea
|
CCR (NCI)
|
|
Targeting the MET pathway in urothelial carcinoma
|
ZIA BC 011594
|
$539,065
|
$539,065
|
Apolo, Andrea
|
CCR (NCI)
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$485,441
|
$485,441
|
Barchi, Joseph
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$71,045
|
Barr, Frederic
|
CCR (NCI)
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$280,052
|
$84,015
|
Beutler, John
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,305,516
|
$645,827
|
Bilusic, Marijo
|
CCR (NCI)
|
|
Hypoxia and Tyrosine Kinase Signaling Integration in Urologic Cancers
|
ZIA BC 011095
|
$200,076
|
$200,076
|
Bottaro, Donald
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$371,569
|
$185,785
|
Bottaro, Donald
|
CCR (NCI)
|
|
Molecular biology of human polyomaviruses
|
ZIA BC 011090
|
$364,996
|
$182,498
|
Buck, Christopher
|
CCR (NCI)
|
|
BKV and JCV vaccine development
|
ZIA BC 011460
|
$364,996
|
$255,497
|
Buck, Christopher
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$198,789
|
$19,879
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,224,110
|
$61,206
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Targeting mechanisms of radiation resistance
|
ZIA BC 011552
|
$372,064
|
$186,032
|
Citrin, Deborah
|
CCR (NCI)
|
|
CCR Genomics Core
|
ZIC BC 011623
|
$854,010
|
$85,401
|
Conner, Elizabeth
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,732,997
|
$736,650
|
Custer, Mary
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$59,098
|
$29,549
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$2,144,166
|
$643,250
|
Edelman, Daniel
|
CCR (NCI)
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$345,321
|
$34,532
|
Figg, William
|
CCR (NCI)
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$252,285
|
$50,457
|
Fowler, Daniel
|
CCR (NCI)
|
|
CCR Confocal Microscopy Core
|
ZIC BC 010858
|
$515,260
|
$51,526
|
Garfield, Susan
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$373,564
|
$22,414
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$971,265
|
$48,563
|
Gottesman, Michael
|
CCR (NCI)
|
|
Experimental Pathology Laboratory (EPL)
|
ZIC BC 011638
|
$1,469,022
|
$146,902
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$852,962
|
$341,185
|
Hou, Steven
|
CCR (NCI)
|
|
Characterization of Biological Nanoparticle Subsets
|
ZIA BC 011502
|
$368,356
|
$18,418
|
Jones, Jennifer
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$7,069
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$526,915
|
$26,346
|
Khan, Javed
|
CCR (NCI)
|
|
Botulinum Toxin for Painful Cutaneous Leiomyomas
|
ZIA BC 011177
|
$10,099
|
$5,050
|
Kong, Heidi
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$247,468
|
$49,494
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,435
|
$386,576
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,030,869
|
$773,152
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,030,869
|
$1,020,561
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$773,152
|
$502,549
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,804,021
|
$1,443,217
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$276,836
|
$27,684
|
Mackem, Susan
|
CCR (NCI)
|
|
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
|
ZIA BC 011488
|
$637,800
|
$127,560
|
Meier, Jordan
|
CCR (NCI)
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$211,049
|
$126,629
|
Merino, Maria
|
CCR (NCI)
|
|
microRNA Profiling in the Spectrum of Kidney Tumors
|
ZIA BC 011405
|
$140,699
|
$140,699
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$211,049
|
$99,193
|
Merino, Maria
|
CCR (NCI)
|
|
Metabolic characterization of FH- and SDH-deficient RCC cell lines
|
ZIA BC 011701
|
$103,268
|
$103,268
|
Moscow, Jeffrey
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $16,734,874
|